Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 20-F/A Annual report (foreign)
- 4.69 Ex - 4.69
- 4.70 Ex -4.70
- 4.71 Ex - 4.71
- 4.72 Ex - 4.72
- 4.73 Ex - 4.73
- 4.74 Ex - 4.74
- 4.75 Ex - 4.75
- 4.76 Ex - 4.76
- 4.77 Ex - 4.77
- 4.78 Ex - 4.78
- 4.79 Ex - 4.79
- 4.80 Ex - 4.80
- 4.81 Ex - 4.81
- 4.82 Ex - 4.82
- 4.83 Ex - 4.83
- 8.1 Ex - 8.1
- 12.1 Ex - 12.1
- 12.2 Ex - 12.2
- 13.1 Ex - 13.1
- 13.2 Ex - 13.2
- 2.1 EX-2.1
- 15.1 Consent of Independent Registered Public Accounting Firm
- Download Excel data file
- View Excel data file
IPCIF similar filings
Filing view
External links
EXHIBIT 4.82
Extension of Debenture Maturity Date
TO Intellipharmaceutics International Inc. (the "Company")
RE: Debenture dated November 15, 2019, for a face amount of US $250,000 issued by the Company to Isa Odidi and Amina Odidi (the "Debenture") and the Maturity Date (as defined in the Debenture and as extended from time to time) of such Debenture
The undersigned hereby agree that the current Maturity Date of the Debenture (currently October 31, 2021) is extended to February 28, 2022.
DATED as of October 31, 2021.
/s/ Isa Odidi | /s/ Amina Odidi | |||
Isa Odidi | Amina Odidi |